live Massive crowds attend Ali Khamenei funeral procession in week-long farewell
Massive crowds are gathering in the streets of Tehran on Monday for the funeral procession of Iran's slain former supreme leader, Ali Khamenei, as ...
A groundbreaking study presented at ASCO reveals that AstraZeneca’s experimental pill camizestrant, when used based on blood test results, can halve the risk of breast cancer progression or death—potentially reshaping treatment for patients with hormone receptor-positive, HER2-negative breast cancer
AstraZeneca’s experimental drug camizestrant significantly reduced the risk of disease progression or death in patients with advanced hormone receptor-positive, HER2-negative breast cancer by 56%, when prescribed based on early blood test results rather than visible tumor growth, experts announced Sunday at the American Society of Clinical Oncology (ASCO) meeting in Chicago.
The international trial marks a major shift in cancer treatment strategy by using liquid biopsy—a blood test that detects ESR1 gene mutations indicating early resistance to standard hormone therapies. Camizestrant, a selective estrogen receptor degrader (SERD), was shown to be effective in patients with early treatment resistance, even before tumors could be detected via imaging.
“This is going to be very impactful for our patients,” said Dr. Hope Rugo, head of breast medical oncology at City of Hope, California. “We’re staying ahead of the curve rather than reacting after the disease has already progressed,” added Dr. Eleonora Teplinsky, another ASCO expert.
The Phase 3 clinical trial involved 3,256 women, all previously treated with aromatase inhibitors and CDK4/6 inhibitors like Pfizer’s Ibrance or Novartis’ Kisqali. Among them, 315 women who developed ESR1 mutations were selected for a randomized trial. Those who switched to camizestrant plus CDK4/6 inhibitors experienced a median 16 months of progression-free survival compared to 9.2 months in the control group that continued standard therapy.
Camizestrant is not yet FDA-approved, but based on these findings, it may soon be adopted as part of a new treatment paradigm for early intervention in breast cancer progression.
AstraZeneca CEO Pascal Soriot acknowledged that integrating liquid biopsy into routine practice would initially be challenging but emphasized it as the future of cancer care.
In a separate announcement at the same ASCO meeting, another AstraZeneca drug, Imfinzi (durvalumab), showed promise in improving outcomes for early-stage stomach and esophageal cancer patients. When added to chemotherapy before and after surgery, Imfinzi reduced the risk of cancer recurrence, progression, or death by 29%.
Both sets of results were published in the New England Journal of Medicine and are expected to have lasting implications for the future of oncology.
The death toll from Venezuela's devastating twin earthquakes has risen to 3,342, according to the country's information ministry, as rescue teams continue searching affected areas and survivors face an uncertain recovery.
Mexico's national football team has returned luxury Rolex watches gifted by American content creator Stevewilldoit after concerns that they could conflict with FIFA's ethics rules.
Governments are tightening restrictions on teenagers’ use of social media amid growing concerns over mental health, online safety and platform design, but questions remain over enforcement and whether bans can meaningfully change behaviour.
President Donald Trump said Iran is keen to reach a deal with the United States, claiming Washington had paused engagement to allow funeral ceremonies for late Iranian Supreme Leader Ali Khamenei.
Thousands of mourners gathered in Tehran on Sunday as Iran held funeral prayers for Ayatollah Ali Khamenei and four members of his family on the second day of mass processions. Three of Khamenei's sons attended the ceremony, while his successor, Mojtaba Khamenei, made no public appearance.
More than 1,300 excess deaths have been recorded across Europe since June 21 as the continent faces extreme heat, World Health Organization Director-General Tedros Adhanom Ghebreyesus said.
The Central African Republic declared a cholera outbreak after 197 cases, including 24 deaths, were confirmed in two health districts southwest of the country’s capital Bangui, local media reported Saturday.
As France endures a record-breaking heatwave that has been linked to at least 40 drowning deaths, forecasters are using three key terms - pic de chaleur, vague de chaleur and canicule. Here's what they mean.
Australian authorities have expanded surveillance and testing efforts after confirming two cases of the highly pathogenic H5N1 bird flu, while neighbouring Papua New Guinea has suspended poultry imports from the country.
The United States has launched an investigation into Germany's pharmaceutical pricing policies to determine whether they unfairly disadvantage American companies and restrict U.S. commerce.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment